TO study efficacy of non cultured, non trypsinised epidermal cell transplantation(a type of skin grafting procedure) in stable(non progressive, resitant to medical treatment) vitiligo.

To study efficacy of autologous non cultured, non trypsinised epidermal cell transplantation in stable vitiligo

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/028973

Enrollment

Registered

2020-11-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Autologous non-cultured, non-trypsinised epidermal cell transplantation in stable vitiligo. : For stable vitiligo resistant to medical management,surgery is the treatment modality.Autol

Eligibility

Inclusion criteria

Inclusion criteria: 12 years and above stable vitiligo

Exclusion criteria

Exclusion criteria: 1.Presence of koebnerâ??s phenomenon 2.Refusal to consent 3.Pregnancy or lactation 4.Patients with unrealistic expectations from treatment 5.Patients with a tendency for keloid formation 6.Active cutaneous infection 7.History suggestive of autoimmune disorders 8.Patient with any hematological or coagulation disorders or on anticoagulation therapy Patients who are immunosuppressed

Design outcomes

Primary

Measure	Time frame
Degree of RepigmentationTimepoint: 16 Week	—

Secondary

Measure	Time frame
Degree of Repigmentation Complications at the site of surgeryTimepoint: 4 week 8 week 16 Week	—

Countries

India

Contacts

Public ContactSheenam

Dr RPG Medical College Kangra

pushpinderschauhan@yahoo.co.in8607201825

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026